Loading…
N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients
Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dys...
Saved in:
Published in: | Yonsei medical journal 2008, 49(4), , pp.625-631 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3 |
---|---|
cites | cdi_FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3 |
container_end_page | 631 |
container_issue | 4 |
container_start_page | 625 |
container_title | Yonsei medical journal |
container_volume | 49 |
creator | Woo, Jeong Joo Koh, Young Youp Kim, Hee Joong Chung, Joong Wha Chang, Kyoung Sig Hong, Soon Pyo |
description | Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dysfunction in cirrhotic patients.
Sixty-three cirrhotic patients and 15 controls (group 1) were enrolled in this study. Plasma levels of NT-proBNP were determined in echocardiographically examined patients, which were allocated to 1 of 3 groups according to Child-Pugh classification or into 2 groups, i.e., a compensated group without ascites (group 2) and decompensated group with ascites (group 3).
Plasma NT-proBNP levels were significantly higher in cirrhotic patients (groups 2 and 3) than in age-matched controls (155.9 and 198.3 vs. 40.3 pg/mL, respectively, p < 0.05). NT-proBNP levels were significantly increased in Child class C patients than in classes B and A (250.0 vs. 168.6 and 119.6 pg/mL, respectively, p < 0.05). Left atrial dimension, wall thickness of left ventricle, and EF or E/E' were significantly increased, and EDT was prolonged in cirrhotic patients than in controls. Increased LVMI and decreased E/A ratio were noted in the group of patients with ascites as compared with the other groups.
Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease. Advanced cirrhosis is associated with advanced cardiac dysfunction, and NT-proBNP levels has predictive value for concomitant cardiac dysfunction and cirrhosis progression. |
doi_str_mv | 10.3349/ymj.2008.49.4.625 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_332358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69475133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3</originalsourceid><addsrcrecordid>eNpVkU2L1TAUhoMoznX0B7iRrMRNaz7apN0I4-DHwKAg4zqcJqfezPS2NUkvdOk_N_cDP1YnJO_75MBDyEvOSimr9u26uy8FY01ZtWVVKlE_IhvealWISurHZMNqLotat-qCPIvxnjGhORNPyQVvtGglUxvy60uRMOz8CAOdw0TfF2mdkY6Qgl8CJm_pjHPyDimMjqYtUtzDsEDy00innloIzoOlbo39Mtrj9SEZcY_Bp_WQcT4iRKR-pNaHsJ2O2IzAMcXn5EkPQ8QX53lJvn_8cHf9ubj9-unm-uq2sJVkqYDOCac70bCuQy601bKule6Y5V3tmhqAK1sxp1TfKN0rzUFi14LuAUTXO3lJ3py4Y-jNg_VmAn-cPybzEMzVt7sbI6WQdZOj707Reel26GxeM8Bg5uB3ENZj8f-X0W8zZm-E4rVoWQa8PgPC9HPBmMzOR4vDACNOSzSqrXR2I3OQn4I2TDEG7P98wpk5ODbZsTk4Nvlcmew4d179u93fxlmq_A08fqd7</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69475133</pqid></control><display><type>article</type><title>N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients</title><source>Open Access: PubMed Central</source><creator>Woo, Jeong Joo ; Koh, Young Youp ; Kim, Hee Joong ; Chung, Joong Wha ; Chang, Kyoung Sig ; Hong, Soon Pyo</creator><creatorcontrib>Woo, Jeong Joo ; Koh, Young Youp ; Kim, Hee Joong ; Chung, Joong Wha ; Chang, Kyoung Sig ; Hong, Soon Pyo</creatorcontrib><description>Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dysfunction in cirrhotic patients.
Sixty-three cirrhotic patients and 15 controls (group 1) were enrolled in this study. Plasma levels of NT-proBNP were determined in echocardiographically examined patients, which were allocated to 1 of 3 groups according to Child-Pugh classification or into 2 groups, i.e., a compensated group without ascites (group 2) and decompensated group with ascites (group 3).
Plasma NT-proBNP levels were significantly higher in cirrhotic patients (groups 2 and 3) than in age-matched controls (155.9 and 198.3 vs. 40.3 pg/mL, respectively, p < 0.05). NT-proBNP levels were significantly increased in Child class C patients than in classes B and A (250.0 vs. 168.6 and 119.6 pg/mL, respectively, p < 0.05). Left atrial dimension, wall thickness of left ventricle, and EF or E/E' were significantly increased, and EDT was prolonged in cirrhotic patients than in controls. Increased LVMI and decreased E/A ratio were noted in the group of patients with ascites as compared with the other groups.
Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease. Advanced cirrhosis is associated with advanced cardiac dysfunction, and NT-proBNP levels has predictive value for concomitant cardiac dysfunction and cirrhosis progression.</description><identifier>ISSN: 0513-5796</identifier><identifier>EISSN: 1976-2437</identifier><identifier>DOI: 10.3349/ymj.2008.49.4.625</identifier><identifier>PMID: 18729306</identifier><language>eng</language><publisher>Korea (South): Yonsei University College of Medicine</publisher><subject>Adult ; Aged ; Electrocardiography ; Female ; Heart Diseases - blood ; Heart Diseases - complications ; Heart Diseases - pathology ; Humans ; Liver Cirrhosis - blood ; Liver Cirrhosis - complications ; Liver Cirrhosis - pathology ; Male ; Middle Aged ; Natriuretic Peptide, Brain - blood ; Original ; 의학일반</subject><ispartof>Yonsei Medical Journal, 2008, 49(4), , pp.625-631</ispartof><rights>Copyright © 2008 The Yonsei University College of Medicine 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3</citedby><cites>FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615290/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615290/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18729306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001271364$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Woo, Jeong Joo</creatorcontrib><creatorcontrib>Koh, Young Youp</creatorcontrib><creatorcontrib>Kim, Hee Joong</creatorcontrib><creatorcontrib>Chung, Joong Wha</creatorcontrib><creatorcontrib>Chang, Kyoung Sig</creatorcontrib><creatorcontrib>Hong, Soon Pyo</creatorcontrib><title>N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients</title><title>Yonsei medical journal</title><addtitle>Yonsei Med J</addtitle><description>Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dysfunction in cirrhotic patients.
Sixty-three cirrhotic patients and 15 controls (group 1) were enrolled in this study. Plasma levels of NT-proBNP were determined in echocardiographically examined patients, which were allocated to 1 of 3 groups according to Child-Pugh classification or into 2 groups, i.e., a compensated group without ascites (group 2) and decompensated group with ascites (group 3).
Plasma NT-proBNP levels were significantly higher in cirrhotic patients (groups 2 and 3) than in age-matched controls (155.9 and 198.3 vs. 40.3 pg/mL, respectively, p < 0.05). NT-proBNP levels were significantly increased in Child class C patients than in classes B and A (250.0 vs. 168.6 and 119.6 pg/mL, respectively, p < 0.05). Left atrial dimension, wall thickness of left ventricle, and EF or E/E' were significantly increased, and EDT was prolonged in cirrhotic patients than in controls. Increased LVMI and decreased E/A ratio were noted in the group of patients with ascites as compared with the other groups.
Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease. Advanced cirrhosis is associated with advanced cardiac dysfunction, and NT-proBNP levels has predictive value for concomitant cardiac dysfunction and cirrhosis progression.</description><subject>Adult</subject><subject>Aged</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Heart Diseases - blood</subject><subject>Heart Diseases - complications</subject><subject>Heart Diseases - pathology</subject><subject>Humans</subject><subject>Liver Cirrhosis - blood</subject><subject>Liver Cirrhosis - complications</subject><subject>Liver Cirrhosis - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Original</subject><subject>의학일반</subject><issn>0513-5796</issn><issn>1976-2437</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkU2L1TAUhoMoznX0B7iRrMRNaz7apN0I4-DHwKAg4zqcJqfezPS2NUkvdOk_N_cDP1YnJO_75MBDyEvOSimr9u26uy8FY01ZtWVVKlE_IhvealWISurHZMNqLotat-qCPIvxnjGhORNPyQVvtGglUxvy60uRMOz8CAOdw0TfF2mdkY6Qgl8CJm_pjHPyDimMjqYtUtzDsEDy00innloIzoOlbo39Mtrj9SEZcY_Bp_WQcT4iRKR-pNaHsJ2O2IzAMcXn5EkPQ8QX53lJvn_8cHf9ubj9-unm-uq2sJVkqYDOCac70bCuQy601bKule6Y5V3tmhqAK1sxp1TfKN0rzUFi14LuAUTXO3lJ3py4Y-jNg_VmAn-cPybzEMzVt7sbI6WQdZOj707Reel26GxeM8Bg5uB3ENZj8f-X0W8zZm-E4rVoWQa8PgPC9HPBmMzOR4vDACNOSzSqrXR2I3OQn4I2TDEG7P98wpk5ODbZsTk4Nvlcmew4d179u93fxlmq_A08fqd7</recordid><startdate>20080830</startdate><enddate>20080830</enddate><creator>Woo, Jeong Joo</creator><creator>Koh, Young Youp</creator><creator>Kim, Hee Joong</creator><creator>Chung, Joong Wha</creator><creator>Chang, Kyoung Sig</creator><creator>Hong, Soon Pyo</creator><general>Yonsei University College of Medicine</general><general>연세대학교의과대학</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>20080830</creationdate><title>N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients</title><author>Woo, Jeong Joo ; Koh, Young Youp ; Kim, Hee Joong ; Chung, Joong Wha ; Chang, Kyoung Sig ; Hong, Soon Pyo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Heart Diseases - blood</topic><topic>Heart Diseases - complications</topic><topic>Heart Diseases - pathology</topic><topic>Humans</topic><topic>Liver Cirrhosis - blood</topic><topic>Liver Cirrhosis - complications</topic><topic>Liver Cirrhosis - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Original</topic><topic>의학일반</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woo, Jeong Joo</creatorcontrib><creatorcontrib>Koh, Young Youp</creatorcontrib><creatorcontrib>Kim, Hee Joong</creatorcontrib><creatorcontrib>Chung, Joong Wha</creatorcontrib><creatorcontrib>Chang, Kyoung Sig</creatorcontrib><creatorcontrib>Hong, Soon Pyo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Yonsei medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woo, Jeong Joo</au><au>Koh, Young Youp</au><au>Kim, Hee Joong</au><au>Chung, Joong Wha</au><au>Chang, Kyoung Sig</au><au>Hong, Soon Pyo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients</atitle><jtitle>Yonsei medical journal</jtitle><addtitle>Yonsei Med J</addtitle><date>2008-08-30</date><risdate>2008</risdate><volume>49</volume><issue>4</issue><spage>625</spage><epage>631</epage><pages>625-631</pages><issn>0513-5796</issn><eissn>1976-2437</eissn><abstract>Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dysfunction in cirrhotic patients.
Sixty-three cirrhotic patients and 15 controls (group 1) were enrolled in this study. Plasma levels of NT-proBNP were determined in echocardiographically examined patients, which were allocated to 1 of 3 groups according to Child-Pugh classification or into 2 groups, i.e., a compensated group without ascites (group 2) and decompensated group with ascites (group 3).
Plasma NT-proBNP levels were significantly higher in cirrhotic patients (groups 2 and 3) than in age-matched controls (155.9 and 198.3 vs. 40.3 pg/mL, respectively, p < 0.05). NT-proBNP levels were significantly increased in Child class C patients than in classes B and A (250.0 vs. 168.6 and 119.6 pg/mL, respectively, p < 0.05). Left atrial dimension, wall thickness of left ventricle, and EF or E/E' were significantly increased, and EDT was prolonged in cirrhotic patients than in controls. Increased LVMI and decreased E/A ratio were noted in the group of patients with ascites as compared with the other groups.
Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease. Advanced cirrhosis is associated with advanced cardiac dysfunction, and NT-proBNP levels has predictive value for concomitant cardiac dysfunction and cirrhosis progression.</abstract><cop>Korea (South)</cop><pub>Yonsei University College of Medicine</pub><pmid>18729306</pmid><doi>10.3349/ymj.2008.49.4.625</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0513-5796 |
ispartof | Yonsei Medical Journal, 2008, 49(4), , pp.625-631 |
issn | 0513-5796 1976-2437 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_332358 |
source | Open Access: PubMed Central |
subjects | Adult Aged Electrocardiography Female Heart Diseases - blood Heart Diseases - complications Heart Diseases - pathology Humans Liver Cirrhosis - blood Liver Cirrhosis - complications Liver Cirrhosis - pathology Male Middle Aged Natriuretic Peptide, Brain - blood Original 의학일반 |
title | N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A48%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-terminal%20pro%20B-type%20natriuretic%20peptide%20and%20the%20evaluation%20of%20cardiac%20dysfunction%20and%20severity%20of%20disease%20in%20cirrhotic%20patients&rft.jtitle=Yonsei%20medical%20journal&rft.au=Woo,%20Jeong%20Joo&rft.date=2008-08-30&rft.volume=49&rft.issue=4&rft.spage=625&rft.epage=631&rft.pages=625-631&rft.issn=0513-5796&rft.eissn=1976-2437&rft_id=info:doi/10.3349/ymj.2008.49.4.625&rft_dat=%3Cproquest_nrf_k%3E69475133%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69475133&rft_id=info:pmid/18729306&rfr_iscdi=true |